Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1369

Lebrikizumab

Home » Antibodies » Lebrikizumab

Background of Lebrikizumab

Lebrikizumab is a humanized monoclonal antibody that targets interleukin-13 (IL-13), a cytokine implicated in the pathogenesis of several inflammatory diseases, including atopic dermatitis (AD). By binding to IL-13, lebrikizumab inhibits its interaction with the IL-13 receptor, thereby modulating the inflammatory response associated with AD. Lebrikizumab represents an innovative approach to treating atopic dermatitis by targeting the IL-13 pathway. Its progression to phase 3 clinical trials underscores the potential of this monoclonal antibody to become a new treatment option for patients with moderate-to-severe AD.

Specifications

Catalog Number:
KB-1369
Antibody Name:
Lebrikizumab
Isotype:
Human IgG4-S228P, kappa
FC Muations:
S228P
Target:
IL13
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al. (September 2011). "Lebrikizumab treatment in adults with asthma". The New England Journal of Medicine. 365 (12): 1088–98.
  2. "Prous Science Molecule of the Month: Lebrikizumab". Thomson Reuters. October 2011. Archived from the original on 26 October 2011. Retrieved 15 December 2011.